JAK3 inhibitors

Pfizer begins phase 2b/3 trial of PF-06651600 to treat alopecia areata
Pharmaceutical Business Review
Fri, 01/4/19 - 09:12 am
Pfizer
clinical trials
PF-06651600
JAK3 inhibitors
alopecia areata
Taxpayer Funds, A Pfizer Drug And Big Profits
Pharmalot
Tue, 03/19/13 - 10:56 am
Pfizer
JAK3 inhibitors
Xeljanz
rheumatoid arthritis
Outlooks for Pfizer, Arena and Onyx Following Busy May
TheStreet.com
Mon, 05/21/12 - 12:28 pm
Pfizer
Arena Pharmaceuticals
Onyx
lorcaserin
JAK3 inhibitors
Merck
Carfilzomib
Phase 2 Data for Selective Oral JAK3 Inhibitor VX-509 Show Significant Improvements in Signs and Symptoms of Rheumatoid Arthritis
Yahoo/BusinessWire
Sun, 11/6/11 - 11:59 am
Vertex Pharmaceuticals
JAK3 inhibitors
VX-509
rheumatoid arthritis